Catalyst Wire Dossier Catalyst Wire Dossier

Cyclosporine 0.05% emulsion (generic)

Cyclosporine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cyclosporine 0.05% emulsion (generic), covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Conjunctival Goblet Cell Density in Dry Eye Patients Treated With Cyclosporine 0.1% Dissolved in Perfluorobutylpentane (Vevye®) or Generic 0.05% Cyclosporine Emulsion for 8 Weeks [Phase 4]

See pricing